Completed PHASE3 INTERVENTIONAL NCT00002517

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome

IDA VS MTZ IN INDUCTION AND INTENSIFICATION TREATMENT OF AML OR MDS IN CHILDREN, A PHASE III RANDOMIZED STUDY

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Conditions Leukemia Myelodysplastic Syndromes

Interventions allogeneic bone marrow transplantation cytarabine daunorubicin hydrochloride dexamethasone etoposide idarubicin mitoxantrone hydrochloride radiation therapy thioguanine

Updated 6 times since 2017 Last updated: Jun 19, 2010 Started: Mar 31, 1993 Primary completion: May 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Leukemia and Myelodysplastic Syndromes and is currently completed. European Organisation for Research and Treatment of Cancer - EORTC leads this study, which shows 6 recorded versions since 1993 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Mar 1993

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

European Organisation for Research and Treatment of Cancer - EORTC

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Angers, France , Antwerp, Belgium , Besançon, France , Brussels, Belgium , Caen, France , Ghent, Belgium , Grenoble, France , Leuven, Belgium , Lille, France , Liège, Belgium and 11 more locations